EIF2AK3 and breast carcinoma: The role of PERK in tumor immunity extends beyond this; a GSEA result indicates that PERK is primarily enriched in immune-related signaling pathways in breast cancer (BRCA), thyroid cancer, and head and neck squamous cell carcinoma (HNSSC).